Skip to content

Insider · CIK 0001674324

5AM Ventures V, L.P.

owner

Files at TRDA (Entrada Therapeutics, Inc.). First filing Jul 1, 2025, latest Nov 18, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $2.8M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

TRDA: Entrada Therapeutics, Inc.

TRDAOct 9, 2026 · close 5.67

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
52Moderate
TRDAsell 3
Entrada Therapeutics, Inc.
$1.8M
200,000 shares
-6%+74% from low-59% from high
32Weak
TRDAsell 2
Entrada Therapeutics, Inc.
$203k
27,000 shares
-1%+13% from low-65% from high
43Moderate
TRDAsell 2
Entrada Therapeutics, Inc.
$867k
125,000 shares
-4%0% from low-68% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Nov 14, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stock
-200,000$8.80$1.8M2,963,066Nov 18, 2025
Jul 9, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stock
-20,065$7.50$151k3,163,066Jul 11, 2025
Jul 9, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stockindirect: By 5AM Opportunities I, L.P.
-6,935$7.50$52k1,093,313Jul 11, 2025
Jun 27, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stock
-55,735$6.91$385k3,220,287Jul 1, 2025
Jun 27, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stockindirect: By 5AM Opportunities I, L.P.
-19,265$6.91$133k1,113,092Jul 1, 2025
Jun 30, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stock
-18,578$6.81$127k3,201,709Jul 1, 2025
Jun 30, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stockindirect: By 5AM Opportunities I, L.P.
-6,422$6.81$44k1,106,670Jul 1, 2025
Jul 1, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stock
-18,578$7.12$132k3,183,131Jul 1, 2025
Jul 1, 2025TRDA
Entrada Therapeutics, Inc.
SOpen-market sale
Common Stockindirect: By 5AM Opportunities I, L.P.
-6,422$7.12$46k1,100,248Jul 1, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.